People who have previously recovered from COVID-19 (Chinese Communist Party virus or CCP virus) should not take a COVID-19 vaccination, according to one of the world’s most qualified and suspicious COVID-19 experts.
“We do know that COVID-recovered patients have a higher side effect rate when they do get needlessly vaccinated,” Dr. Peter A. McCullough told LifeSiteNews, quoted scientific papers indicating that naturally immune people had a higher likelihood of vaccination harms.
“Really, under no circumstances should a fully-recovered patient receive a COVID-19 vaccine … and authorities should accept that.”
An insider COVID doctor
Last Friday, July 30, cardiologist, internist epidemiologist, academic researcher, and journal editor McCullough spoke with LifeSiteNews about his work with CCP virus patients.
When LifeSiteNews asked McCullough about his credentials, he emphasized the multidisciplinary approach he has used throughout his medical career.
“I’m one of a handful—I’d say probably less than 4% of cardiologists—that maintained my board certifications in internal medicine, and … I did three years of rural internal medicine after my residency at the University of Washington in Seattle,” he said.
“I handled common infectious diseases and always taught myself to be well-rounded. I’m a medical cardiologist,” he continued.
“I really focus comprehensively on patient care, and when COVID-19 hit, it really hit seniors, which is my patient population, with heart disease, lung disease and kidney [disease], so I felt very much in the crosshairs as a doctor to do everything I could to help patients with COVID-19.”
Over a hundred COVID-19 patients have been directly managed by McCullough, who has also advised on “many hundreds if not a thousand” of cases worldwide.
Currently, the doctor is directly caring for four people. He’s also observed young males who developed heart difficulties after receiving the COVID vaccine. There have been 2,800 confirmed cases of post-vaccination myocarditis in the U.S. as of July 15. McCullough has reported many cases of myocarditis to the US Centers for Disease Control and Prevention and has discussed them with them (CDC).
Delta variant breaks through the current COVID-19 vaccines
In response to a recent Washington Post article claiming that those vaccinated are just as likely as those who have not been vaccinated to spread the Delta strain of CCP Virus, McCullough stated the data is backed up by past research he has looked into. He referenced well-known examples such as the Texas Democrat legislators who flew together to Washington, D.C., and contracted COVID-19 despite being vaccinated.
“As a matter of fact, this week the health minister for New South Wales in Australia reported that the number of patients in Australian hospitals there with COVID-19 was over 300, and … all of those people were fully vaccinated, except for one,” the doctor told LifeSiteNews.
According to McCullough, the Delta variant, which accounted for nearly 100 percent of new COVID cases in north Texas, appears to be resistant to the vaccines. He believes that the government should now do a thorough analysis to determine which vaccines are truly effective.
The statistics from Israel, which uses the Pfizer vaccination exclusively, have struck the expert. Although 80 percent of Israel’s population has been vaccinated, 84 percent of the latest 5000 cases reported on July 24 had already been vaccinated.
“So it appears in at least exclusively Pfizer vaccinated populations that we’re clearly seeing a uniform breakthrough of cases, or at least a uniform vaccination rate of those breaking through,” McCullough remarked.
There are mixed results in nations where several vaccines have been attempted, yet there is still evidence of “breakthrough infections.” In the UK, 42 percent of the nearly 200,000 persons who became ill from the Delta variant and had to go to be hospitalized had previously been vaccinated. 460 people have died out of 200,000, with 65 percent of them having been vaccinated.
“That’s a deathrate of less than 0.2%, so Delta is clearly a milder strain—or less fatal strain, but the vaccination—one would have to look at those numbers and conclude that breakthrough is readily accomplished with the Delta variant in forms of vaccination in the UK,” McCullough said.
A better, safer vaccine?
Patients have been asking McCullough which vaccine is most effective against the Delta strain because both the UK and the U.S. have been delivering a range of immunizations.
“We critically need that analysis from our leaders,” he said.
As a doctor, McCullough said he’s looked at trials of a vaccine called Novavax, which is antigen-based rather than mRNA-based, and he’s extremely optimistic about it.
Novavax is not made with cell lines obtained from aborted children’s cells, according to the pro-life Charlotte Lozier Institute. However, it appears that some of the vaccine’s experiments included contentious cell lines.
“I [saw] rates of vaccine effectiveness over 2 to 5 months of 90%,” McCullough stated, but he was careful to point out that the research was done before the Delta form became prevalent. Nonetheless, he remains optimistic that Novavax will provide a “broader amount” of protection with a lower chance of vaccine harm.
“It would be my understanding as a doctor, that this could be less likely to have these internal organ effects that we’re seeing with the other vaccines.”
The next step of the immunization effort, according to McCullough, will aim to replace the mRNA vaccines with two-dose Novavax and other antigenic vaccines, which have a higher “safety profile and a broader coverage.” Nonetheless, he noted that the Pfizer, Moderna, and Johnson & Johnson vaccines all had a favorable short-term safety profile.
“Now, that we get these out in the broad population, that’s when we see the concerning events including death and then non-fatal injuries,” he said.
So, who should get vaccinated? McCullough has observed that patients above the age of 50 had a rate of hospitalization and death of over 1%, with the rate increasing as the patient’s age increases. As a result, McCullough believes that a safe vaccine for the over-50s should be studied. He also considers 50 to be a watershed moment in the importance of early cancer therapy and has published two studies on the subject.
The current vaccines ‘are not sufficiently fit for human use’
The doctor claims that the U.S. CDC and FDA have never given an official briefing on vaccine safety and efficacy. Although the CDC has received over 400,000 “safety events,” the VAERS figures are available, and the CDC releases a “variant report,” there is no guidance on whether vaccination is better.
According to McCullough, current vaccines are “not sufficiently fit for human use” and should no longer be used.
“I’m in line with the evidence-based consulting group in the United Kingdom, and they’re the principal consultant to the World Health Organization,” he told LifeSiteNews.
“Their official report to the MHRA, the regulatory body in England, is actually not to move forward with the current vaccines, that they’re not sufficiently fit for human use and, in the absence of any of data and analyses, they should… close down the program.”
Meanwhile, fewer people than you may believe have been getting vaccines from Pfizer, AstraZeneca, Moderna, and other companies.
“We have less than 20% of the population that has taken any vaccine at all,” McCullough said.
“There are countries that are showing a lot of discernment and reservations, including Japan.”
Other countries have “drawn some lines,” he noted, citing the United Kingdom and Germany as examples of countries that do not allow youngsters to be vaccinated.
In the U.S., 48 percent of people have been vaccinated, leaving 52 percent unvaccinated.
“Vaccine centers have been very, very under-utilized over the past few months,” McCullough told LifeSiteNews.
“There’s great concern in America about the efficacy and safety of the vaccines. Our rate of vaccination has slowed to a halt.”
Stopping COVID-19 over your bathroom sink
In the hopes of warding off the coronavirus, many people have been taking Vitamin D and over-the-counter medications. To avoid being ill with the CCP virus, McCullough told LifeSiteNews that there are “very interesting” nose and dental hygiene routines. Medical advice on tooth cleaning, swishing, and spitting with various solutions, including “anti-infective yellow Listerine mouthwash,” he claimed, may be found online.
“Also there’s oral povidone-iodine that has been tested in clinical trials, successful,” he continued.
“Oral hydrogen peroxide. Even oral dilute sodium hypochlorite which is actually household bleach that’s diluted—5 ccs in 500 ccs.”
According to McCullough, the American Dental Association accepts this dilute bleach as an anti-infective in the mouth if it is swished around and spat out [not swallowed] twice a day for other viruses. Anti-infective nasal sprays, as well as doses of oral ivermectin and oral hydroxychloroquine, could be used to protect against the coronavirus, according to the early-treatment expert.
“Those protocols are available through the frontline critical care consortium,” he said.
“It’s got a nice offering of prophylactic protocols. In the United States, it is offered through telemedicine services. The lead one is MyFreeDoctor.com.”
McCullough admitted being hesitant when he first heard former President Donald Trump mention bleach as a COVID-19 prophylactic, but he told LifeSiteNews that he is impressed by the lack of COVID-19 transmission in dental offices, especially because dentists are “all day long” near mouths and noses.
In terms of early CCP virus treatment, the doctor remains optimistic about monoclonal antibodies with emergency use authorization, particularly the present Regeneron product. When President Trump contracted COVID-19 in October 2020, he underwent this treatment.
Elderly individuals who have recently developed COVID-19, according to McCullough, should begin therapy as soon as possible by receiving a monoclonal antibody injection in an outpatient ER that lasts more than an hour. He said that the U.S. government had purchased five million doses of the medication, which is being underutilized.
“It’s the best way to treat a high-risk case,” the doctor said and added that It was also suitable for those who had been “fully vaccinated” yet would still contract the illness. Treatment with hydroxychloroquine (“supported by 200 studies”) and ivermectin (“supported by 60 studies”) might be “layered in” after the high-risk patient has received the monoclonal antibody infusion.
He also highlighted aspirin, which is effective in coronavirus treatment studies.
“In total, it’s four to six drugs,” McCullough said.
“The doctor decides based on how far along the patient is into the illness, and what the symptoms are.”
The importance of timing cannot be overstated. People are looking for monoclonal antibody infusions when the infection is so far progressed that the patient has poor oxygen saturation, according to McCullough, which is the biggest mistake he encounters. He added that there was an issue with blood clotting at that moment, and the patient required a substantial dose of aspirin and anti-coagulant injections.
This form of treatment may surprise COVID-free persons who sought aid from their doctors and were encouraged to self-isolate and drink a lot of water. Many doctors, according to McCullough, are hesitant to give ivermectin and hydroxychloroquine because they are afraid of a “reprisal.”
“They’re actually afraid of having their medical licenses reviewed for trying to care for COVID-19 patients and help them,” he said.
On the other hand, other doctors have told McCullough that they treat patients without using either drug because they “simply time the illness,” provide anti-inflammatories, and utilize blood thinners.
“The bottom line is that they can still successfully treat COVID,” he said.
The doctor continued: “You know, 85% of the hospitalizations and deaths don’t have to happen.”
He argues that in the event of a high-risk senior CCP virus patient, the “worst thing” is not to treat them at all and to leave them at home until they become so ill that they need to be hospitalized.
Good news for the healthy under-50s
COVID-19, on the other hand, poses no hazard to the majority of the population. According to McCullough, the coronavirus has infected less than 1% of the general population. Doctors are aware of the high-risk population, including adults in their 50s and those with several medical issues.
According to McCullough, many young people who contract COVID-19, particularly the Delta variant, which McCullough considers to be the mildest strain, recover “very easily” and develop “robust, complete and durable” natural immunity. According to the doctor, natural immunity works better than vaccines since the rate of reinfection is so low.
“Natural immunity is the best of all forms of immunity,” McCullough declared and said that those who have recovered from COVID-19 are “not of any harm to anyone else, and they don’t have to be careful.”
They must, however, take care not to be vaccinated. According to McCullough, people who have recovered with COVID-19 have a high risk of negative effects if they are vaccinated against it. He argues that persons who are naturally immune to the CCP virus should not receive the vaccine. Authorities should exempt naturally immune people from vaccine requirements, the doctor said.
Censorship and lawsuit
Unfortunately, McCullough has been subjected to the same penalties as other doctors who dispute the conventional COVID-19 and COVID-19 vaccine narratives. Despite being a leader in all of the medical centers where he has worked, McCullough has lost contracts and a professorship. He is currently being sued by Baylor University, which alleges he has been abusing his professional credentials and, in a way, represents Baylor and Texas A&M College of Medicine.
“My response to that is I’ve been very judicious in how I present myself in my spoken words and written words. I’ve never falsely claimed a prior title,” he said.
Given the volume of material written by and about McCullough on the internet, with hundreds upon thousands of clicks, he can’t remove all references to his previous titles and positions. He also has no say in how the television media portrays him in on-screen banners.
“That’s actually the genesis of the lawsuit which is now financially and professionally damaging for me,” he said.
“I’m being professionally damaged and humiliated largely for my hard work in trying to save lives from COVID-19 and my careful review of the data with respect to the vaccine.”